Since the discovery of its role in the CNS, glutamate, together with its in
volvement in signalling at synapses, has been the subject of a vast amount
of research. More recently, it has become clear that glutamate signalling i
s also functional in non-neuronal tissues and occurs in sites as diverse as
bone, pancreas and skin. These findings raise the possibility that glutama
te acts as a more widespread 'cytokine' and is able to influence cellular a
ctivity in a range of tissue types. The impact of these discoveries is sign
ificant because they offer a rapid way to advance the development of therap
eutics. Agents developed for use in neuroscience applications might be bene
ficial in the modulation of pathology peripherally, impacting on conditions
such as osteoporosis, diabetes and wound healing.